Dexamethasone for bronchiolitis [1]

New England Journal of Medicine

Volumn 357, Issue 16, 2007, Pages 1659-1660

  La Shell, Mark S ^a   Calabria, Christopher W ^a  

^a WILFORD HALL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; STEROID; GLUCOCORTICOID;

BRONCHIOLITIS; CLINICAL TRIAL; DRUG EFFICACY; FOLLOW UP; HUMAN; LETTER; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECURRENCE RISK; RHINOVIRUS; WHEEZING; ABNORMAL RESPIRATORY SOUND; NOTE; ORAL DRUG ADMINISTRATION; COMMON COLD; DRUG EFFECT; AUSTRALIA; CLINICAL FEATURE; UNITED KINGDOM; UNITED STATES;

ADMINISTRATION, ORAL; BRONCHIOLITIS; DEXAMETHASONE; GLUCOCORTICOIDS; HUMANS; RESPIRATORY SOUNDS; COMMON COLD;

EID: 35348990736     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc072465     Document Type: Letter

References (4)

1. Corneli HM, Zorc JJ, Majahan P, et al. A multicenter, randomized, controlled trial of dexamethasone for bronchiolitis. N Engl J Med 2007;357:331-9.
2. Lehtinen P, Ruohola A, Vanto T, Vuorinen T, Ruuskanen O, Jartti T. Prednisolone reduces recurrent wheezing after a first wheezing episode associated with rhinovirus infection or eczema. J Allergy Clin Immunol 2007;119:570-5.
3. Papadopoulos NG, Moustaki M, Tsolia M, et al. Association of rhinovirus infection with increased disease severity in acute bronchiolitis. Am J Respir Crit Care Med 2002;165:1285-9.
4. Lemanske RF Jr, Jackson DJ, Gangnon RE, et al. Rhinovirus illnesses during infancy predict subsequent childhood wheezing. J Allergy Clin Immunol 2005;116:571-7.